Japanese tech group Teijin Ltd. is broadening its orthopedics portfolio by taking a majority stake in the bone-fixation business of Takiron.
Teijin will acquire an 86% share of the Osaka-based business, which sells the Osteotrans family of bioactive and resorbable osteosynthetic...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?